<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346880</article-id>
      <article-id pub-id-type="pmc">3876003</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132441</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cutaneous metastasis of colon adenocarcinoma: case report and review of
the literature<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Met&#xE1;stasis cut&#xE2;nea de adenocarcinoma colorretal: relato de caso e
revis&#xE3;o da literatura</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nesseris</surname>
            <given-names>Ioannis</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsamakis</surname>
            <given-names>Charalambos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gregoriou</surname>
            <given-names>Stamatis</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ditsos</surname>
            <given-names>Ilias</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Christofidou</surname>
            <given-names>Eleftheria</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rigopoulos</surname>
            <given-names>Dimitris</given-names>
          </name>
          <xref ref-type="aff" rid="aff06">6</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Consultant, Pathology Department, Andreas Sygros Hospital -
Athens, Greece.</aff>
      <aff id="aff02"><label>2</label> MD - Senior Registrar, Attikon Hospital - Xaidari, Greece.</aff>
      <aff id="aff03"><label>3</label> MD, PhD - Consultant, University of Athens Medical School, Dermatology
Department, Attikon Hospital - Xaidari, Greece.</aff>
      <aff id="aff04"><label>4</label> MD - Dermatologist Venereologist, Fellow of the University of Athens
Medical School, Dermatology Department, Attikon Hospital - Xaidari, Greece.</aff>
      <aff id="aff05"><label>5</label> MD, PhD - Consultant, Pathology Department, Andreas Sygros Hospital -
Athens, Greece.</aff>
      <aff id="aff06"><label>6</label> AdHoc - AdHoc University of Athens, Department of Dermatology, Attikon
Hospital - Xaidari, Greece.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Dimitris Rigopoulos, University of Athens Medical
school, Dermatology Department, Attikon Hospital, 1 Rimini Str, 12462 - Athens -
Greece. E-mail: <email>stamgreg@yahoo.gr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>56</fpage>
      <lpage>58</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Skin metastases from colorectal carcinoma are rare and signal advanced disease. We
present a case of an 80-year-old male with a large skin metastatic focus in the lower
abdomen, a year after resection of a colonic adenocarcinoma. The patient had already
finished receiving his first cycle of chemotherapy shortly before the discovery of
the abdominal nodules and at the same period a chest X-ray, revealed shadows at the
base of the right lung.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Met&#xE1;stases cut&#xE1;neas provocadas por carcinoma colorretal s&#xE3;o raras e sinalizam doen&#xE7;a
avan&#xE7;ada. Apresentamos o caso de um homem de 80 anos com um grande foco metast&#xE1;tico
na pele do baixo abd&#xF4;men, um ano ap&#xF3;s a ressec&#xE7;&#xE3;o de um adenocarcinoma do c&#xF3;lon. O
paciente j&#xE1; havia acabado de receber o seu primeiro ciclo de quimioterapia pouco
antes da descoberta dos n&#xF3;dulos abdominais e, no mesmo per&#xED;odo, um raio-X do t&#xF3;rax
revelou sombras na base do pulm&#xE3;o direito.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Adenocarcinoma</kwd>
        <kwd>Neoplasm Metastasis</kwd>
        <kwd>Skin neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Skin metastases from colorectal carcinoma are rare and usually appear within two years
after resection of the primary tumor. They typically signify widespread disease with
poor prognosis.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup> We present a case of an 80-year- old male with a large
skin metastatic focus on the lower abdomen about a year after resection of a colonic
adenocarcinoma. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>An 80-year-old male presented at the outpatient clinic with a growing mass on the
abdominal skin. (<xref ref-type="fig" rid="f01">Figure 1</xref>). On clinical
examination, a diffuse erythematous multinodular cauliflower-like lesion was evident,
with satellite nodules located in the periumbilical and lower abdominal region. A zone
of pink indurated erythema surrounded the central mass. A large scar was evident at the
base of the mass suggesting previous abdominal surgery and possible initial eruption of
the mass on the scarred site.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Multinodular lesion with satellite nodules on an erythematous base, measuring
19X8.5x2 cm, on the abdominal skin.</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0056-g01"/>
      </fig>
      <p>The patient had a history of colorectal adenocarcinoma. He was initially hospitalized
for hematochezia 12 months previously. Colonoscopy showed a cauliflower-like mass at the
right flexure of the colon, and various polyps. A right hemi-colectomy was performed and
histopathology showed a mucinous adenocarcinoma, with vascular and lymphatic emboli. No
distant metastasis was found. The adenocarcinoma was staged T3N1M0. A month later, the
patient started receiving 5-fluorouracil-based adjuvant chemotherapy for six months.
Four months after the first cycle of chemotherapy was concluded, a chest X-ray was
performed. This revealed shadows at the base of the right lung. It was interpreted by
the radiologists as a possible spread of the known adenocarcinoma. </p>
      <p>We obtained a biopsy specimen of the abdominal lesion. On microscopic examination the
dermis was infiltrated by a number of adenomatous glands with obvious atypia and
mucinous content, which was consistent with a metastatic focus of the known mucinous
colon adenocarcinoma (<xref ref-type="fig" rid="f02">Figures 2</xref> and <xref ref-type="fig" rid="f03">3</xref>). </p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Histologic section of metastatic foci of the skin: irregular branching and
cribriform glands with pseudostratified columnar epithelium; luminal mucus and
inflammatory cells. H&amp;E x40</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0056-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Histologic section of metastatic foci of the skin: irregular branching and
cribriform glands with pseudostratified columnar epithelium; luminal mucus and
inflammatory cells. H&amp;E x40</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0056-g03"/>
      </fig>
      <p>Computerized axial tomography was unremarkable with the exception of the right lung
shadow. </p>
      <p>The patient is currently receiving his second cycle of chemotherapy and is in good
overall condition. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Skin metastasis of cancer is rare, occurring in 0.7 - 5% of cancer patients. Increased
frequency of up to 9% has been reported in selected patient series.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup>
Cutaneous metastasis among patients with metastatic cancer has been reported to be
10.4%.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Breast cancer is the most common primary cancer with cutaneous metastasis, with an
incidence of 24% according to a meta-analysis by Krathen <italic>et
al</italic>.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> Lung cancer,
colorectal cancer, renal cancer, ovarian cancer and bladder cancer all have similar
rates of cutaneous metastasis ranging between 3.4-4.0%.<sup><xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>Frequency of skin metastasis of colorectal carcinoma has been reported to be
2.3-6%.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup> Interestingly, according to a 2008 Taiwanese study, the
rate of cutaneous metastasis from colorectal carcinoma is 0.81%, suggesting a remarkable
difference in frequencies between Caucasian and Taiwanese patient populations.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>Skin metastases from colorectal adenocarcinoma generally occur within the first two
years after resection of the primary tumor and often present simultaneously with
metastases to the liver, peritoneum and lung.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> The most frequent site of cutaneous metastasis of colonic cancer
is the abdominal skin, often on surgical incision scars. This is not exclusive to the
<italic>ad hoc </italic>surgical incision scar, but also to preexisting unrelated
operative scars.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Other cutaneous
sites in order of decreasing frequency are the pelvis, back, chest, upper extremities,
head and neck.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> Uncommon reported
sites of skin metastasis of colorectal cancer include scalp, face, eyelids, tip of the
nose, nostril, forearm, genitalia, ankle and big toe.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup> Umbilical
metastasis (Sister Mary Joseph's nodule) is a recurrent finding.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Cutaneous metastasis may occur through lymphogenous spread, intravascular dissemination,
direct extension of tumor and surgical implantation.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> Wong <italic>et al </italic>added the spread along embryonal
remnants such as the urachus to the aforementioned mechanisms.<sup><xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Metastatic carcinoma can assume a variety of morphologic appearances.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> It usually presents as violaceous to
flesh-colored, firm, freely mobile, painless nodules , single or multiple. It can
sometimes mimic epidermal cysts, neurofibromas, lipomas, cicatricial morphea-like
plaques, lymphoma and alopecia.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> More
rarely it can mimic infection, and present as a zone of pink to deep red or purplish red
indurated erythema with a well-demarcated border, a condition termed inflammatory
metastatic carcinoma or carcinoma erysipelatoides.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> Data regarding the macroscopic appearance of cutaneous metastatic
lesions of colonic carcinoma, is scarce in the medical literature. In a large series by
Lookingbill <italic>et al</italic>, all the remote metastases were described as
nodular.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Histologic features of metastatic lesions in general resemble those of the primary
tumor. However, metastases are frequently more anaplastic. With the exception of renal
cell carcinoma, metastases do not always permit identification of the primary
tumor.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Skin metastases can be
broadly classified as adenocarcinoma, squamous carcinoma, undifferentiated carcinoma and
other types.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> Most skin metastases
from large intestine tumors are well differentiated, often mucin-secreting
adenocarcinomas. They usually have a nodular configuration and are located in the
dermis, with subsequent spread to the epidermis and subcutaneous tissue.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Identification of skin metastasis from an internal malignancy is considered a poor
prognostic sign, as it reflects widespread disease.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> Survival after diagnosis of cutaneous metastasis ranges from 1 to
34 months. The average survival of patients after diagnosis of skin metastasis from
colon cancer is, according to Lookingbill <italic>et al</italic>., 18 months.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Wide local excision of the cutaneous metastatic lesion is the preferred treatment option
in isolated lesions. In cases of extensive cutaneous metastases treatment is only
palliative. Extensive tumor resection of those neoplasms can result in giant abdominal
wall defects. Reconstruction of the abdominal wall is not easy for an average general
surgeon or even a plastic surgeon. Most reports describe reconstructing giant abdominal
wall defects by using synthetic mesh implants, autologous tissue graft, or a combination
of the two.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> No clear guidelines exist
for an optimum chemotherapeutic regimen. Established chemotherapy treatments include
5-fluorouracil, capecitabine, irinotecan, oxaliplatin and cisplatin. Combinations of
irinotecan to bolus 5-FU, oxaliplatin to infusional 5FU and leucovorin (LV) (FOLFOX) or
infusional 5FU/LV with irinotecan (FOLFIRI) has increased survival to over 20 months.
Treating patients sequentially with FOLFIRI followed by FOLFOX, or with FOLFOX followed
by FOLFIRI, has increased the median survival times to 21.5 months and 20.6 months
respectively.<sup><xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at the University of Athens Medical School, 2nd Dermatology
Department, Attikon Hospital - Athens, Greece.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verardino</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Obadia</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Gripp</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Alves Mde</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Rare cutaneous metastasis from a probable basaloid carcinoma of the
colon mimicking pyogenic granuloma</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>537</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="pmid">21738971</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lookingbill</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Spangler</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sexton</surname>
              <given-names>FM</given-names>
            </name>
          </person-group>
          <article-title>Skin involvement as the presenting sign of internal carcinoma. A
retrospective study of 7316 cancer patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1990</year>
          <volume>22</volume>
          <fpage>19</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">2298962</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Humaire</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Sister Mary Joseph's nodule: a sign of internal
malignancy</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S118</fpage>
          <lpage>S120</lpage>
          <pub-id pub-id-type="pmid">22068789</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lookingbill</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Spangler</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>KF</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastases in patients with metastatic carcinoma: a
retrospective study of 4020 patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1993</year>
          <volume>29</volume>
          <fpage>228</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">8335743</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krathen</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Orengo</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastasis: A meta-analysis of data</article-title>
          <source>South Med J</source>
          <year>2003</year>
          <volume>96</volume>
          <fpage>164</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="pmid">12630642</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Chai</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Lan</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Rates of cutaneous metastases from different internal malignancies:
Experience from a Taiwanese medical center</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2009</year>
          <volume>60</volume>
          <fpage>379</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="pmid">19056145</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Toh</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Koo</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory metastatic carcinoma of the colon: A case report and
review of the literature</article-title>
          <source>Tumori</source>
          <year>2004</year>
          <volume>90</volume>
          <fpage>253</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">15237593</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kauffman</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sina</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Metastatic inflammatory carcinoma of the rectum: tumour spread by
three routes</article-title>
          <source>Am J Dermatopathol</source>
          <year>1997</year>
          <volume>19</volume>
          <fpage>528</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="pmid">9335247</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>DQ</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>YL</given-names>
            </name>
          </person-group>
          <article-title>Reconstruction of the abdominal wall by using a combination of the
human acellular dermal matrix implant and an interpositional omentum flap after
extensive tumor resection in patients with abdominal wall neoplasm: a preliminary
result</article-title>
          <source>World J Gastroenterol</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>752</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="pmid">18205267</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tournigand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Andr&#xE9;</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Achille</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lledo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Flesh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mery-Mignard</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced
colorectal cancer: a randomized GERCOR study</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>229</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="pmid">14657227</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
